Verastem | VSTM - Ordinary Share Capital

Stock Price
6.09
Daily Change
-0.44 -6.67%
Monthly
12.89%
Yearly
-13.57%
Q2 Forecast
6.44

Verastem reported $77.74M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alaunos Therapeutics USD 2.21M 131K Sep/2025
AstraZeneca USD 1.55B 206K Dec/2025
Curis USD 12.93M 12.87M Dec/2025
Cytokinetics USD 122.26M 145K Dec/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
Laboratory Of America USD 82.2M 700K Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025
Verastem USD 77.74M 77.74M Dec/2025